[Expression Level of S100A6 mRNA in MM and Its Clinical Significance].
作者信息
Bao Hong-Yu, Wang Jian-Nin, Meng Qing-Qi, Song Min, Fu Xing-Cai, Hou Yan-Qiu, Zhang Liu-Bo, Jiang Su-Yu
机构信息
Department of Hematology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu Province, China. E-mail:
Department of Hematology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, Jiangsu Province, China.
出版信息
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Oct;24(5):1466-1469. doi: 10.7534/j.issn.1009-2137.2016.05.033.
OBJECTIVE
To investigate the expression level of S100A6 mRNA in MM and to its clinical significance, and to evaluate its significance.
METHODS
The expression level of S100A6 mRNA in MM patients was determined by real time quantitative PCR(RQ-PCR), and its relationship with the clinical features and outcomes of patients was analyzed by statistic method.
RESULTS
S100A6 mRNA was detected in 20 MM patients. Compared with normal persons, the S100A6 mRNA expression in MM patients was higher. In different groups, the S100A6 mRNA expression in MM patients of 3 stages was higer than that in patients of 1 and 2 stages. MM patients with higher S100A6 mRNA expression had poor prognosis and higer extramedullary metastasis rate.
CONCLUSION
The high expression of S100A6 mRNA is associated with poor prognosis and may be a prognostic molecular marker of MM.
Zotero 插件